INDIVIOR PLC (INDV) Stock Fundamental Analysis
USA - NASDAQ:INDV - GB00BN4HT335 - Common Stock
25.31 USD
+0.41 (+1.65%)
Taking everything into account, INDV scores 4 out of 10 in our fundamental rating. INDV was compared to 191 industry peers in the Pharmaceuticals industry. INDV has an average financial health and profitability rating. INDV has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
INDV had positive earnings in the past year.
INDV had a positive operating cash flow in the past year.
In multiple years INDV reported negative net income over the last 5 years.
In multiple years INDV reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of INDV (-4.00%) is better than 73.30% of its industry peers.
The Return On Invested Capital of INDV (111.88%) is better than 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for INDV is significantly above the industry average of 15.45%.
The 3 year average ROIC (43.06%) for INDV is below the current ROIC(111.88%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4% | ||
| ROE | N/A | ||
| ROIC | 111.88% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
1.3 Margins
In the last couple of years the Profit Margin of INDV has declined.
INDV's Operating Margin of 25.44% is amongst the best of the industry. INDV outperforms 92.15% of its industry peers.
In the last couple of years the Operating Margin of INDV has remained more or less at the same level.
The Gross Margin of INDV (83.98%) is better than 88.48% of its industry peers.
In the last couple of years the Gross Margin of INDV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.44% | ||
| PM (TTM) | N/A | ||
| GM | 83.98% |
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so INDV is creating value.
INDV has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, INDV has less shares outstanding
The debt/assets ratio for INDV is higher compared to a year ago.
2.2 Solvency
INDV has an Altman-Z score of 3.36. This indicates that INDV is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of INDV (3.36) is better than 72.77% of its industry peers.
The Debt to FCF ratio of INDV is 2.49, which is a good value as it means it would take INDV, 2.49 years of fcf income to pay off all of its debts.
INDV's Debt to FCF ratio of 2.49 is amongst the best of the industry. INDV outperforms 91.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.49 | ||
| Altman-Z | 3.36 |
ROIC/WACC12.04
WACC9.29%
2.3 Liquidity
A Current Ratio of 0.88 indicates that INDV may have some problems paying its short term obligations.
With a Current ratio value of 0.88, INDV is not doing good in the industry: 86.39% of the companies in the same industry are doing better.
A Quick Ratio of 0.72 indicates that INDV may have some problems paying its short term obligations.
INDV has a worse Quick ratio (0.72) than 85.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
INDV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.28%.
INDV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -29.07% yearly.
INDV shows a small growth in Revenue. In the last year, the Revenue has grown by 4.34%.
Measured over the past years, INDV shows a decrease in Revenue. The Revenue has been decreasing by -4.53% on average per year.
EPS 1Y (TTM)-24.28%
EPS 3Y-29.07%
EPS 5YN/A
EPS Q2Q%15.91%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y-4.53%
Revenue growth 5YN/A
Sales Q2Q%1%
3.2 Future
Based on estimates for the next years, INDV will show a very negative growth in Earnings Per Share. The EPS will decrease by -15.65% on average per year.
The Revenue is expected to decrease by -6.61% on average over the next years.
EPS Next Y8.11%
EPS Next 2Y-1.39%
EPS Next 3Y-10.28%
EPS Next 5Y-15.65%
Revenue Next Year3.53%
Revenue Next 2Y-2.92%
Revenue Next 3Y-9.06%
Revenue Next 5Y-6.61%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 14.46, which indicates a correct valuation of INDV.
Based on the Price/Earnings ratio, INDV is valued cheaply inside the industry as 87.43% of the companies are valued more expensively.
INDV is valuated rather cheaply when we compare the Price/Earnings ratio to 27.57, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 14.87, which indicates a correct valuation of INDV.
81.68% of the companies in the same industry are more expensive than INDV, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.09. INDV is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.46 | ||
| Fwd PE | 14.87 |
4.2 Price Multiples
97.38% of the companies in the same industry are more expensive than INDV, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, INDV is valued cheaper than 83.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.92 | ||
| EV/EBITDA | 5.58 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of INDV may justify a higher PE ratio.
A cheap valuation may be justified as INDV's earnings are expected to decrease with -10.28% in the coming years.
PEG (NY)1.78
PEG (5Y)N/A
EPS Next 2Y-1.39%
EPS Next 3Y-10.28%
5. Dividend
5.1 Amount
No dividends for INDV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:INDV (10/23/2025, 3:10:00 PM)
25.31
+0.41 (+1.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners94.68%
Inst Owner Change0.34%
Ins Owners3.79%
Ins Owner ChangeN/A
Market Cap3.16B
Revenue(TTM)1.06B
Net Income(TTM)-55000000
Analysts82.5
Price Target14.88 (-41.21%)
Short Float %5.54%
Short Ratio2.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.46 | ||
| Fwd PE | 14.87 | ||
| P/S | 1.53 | ||
| P/FCF | 23.92 | ||
| P/OCF | 19.02 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.58 |
EPS(TTM)1.75
EY6.91%
EPS(NY)1.7
Fwd EY6.72%
FCF(TTM)1.06
FCFY4.18%
OCF(TTM)1.33
OCFY5.26%
SpS16.51
BVpS-2.28
TBVpS-2.34
PEG (NY)1.78
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4% | ||
| ROE | N/A | ||
| ROCE | 141.62% | ||
| ROIC | 111.88% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 25.44% | ||
| PM (TTM) | N/A | ||
| GM | 83.98% | ||
| FCFM | 6.41% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)54.5%
ROCE(5y)38.6%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
F-Score5
Asset Turnover1.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.49 | ||
| Debt/EBITDA | 0.57 | ||
| Cap/Depr | 136% | ||
| Cap/Sales | 1.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.24% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 3.36 |
F-Score5
WACC9.29%
ROIC/WACC12.04
Cap/Depr(3y)163.83%
Cap/Depr(5y)132.28%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.28%
EPS 3Y-29.07%
EPS 5YN/A
EPS Q2Q%15.91%
EPS Next Y8.11%
EPS Next 2Y-1.39%
EPS Next 3Y-10.28%
EPS Next 5Y-15.65%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y-4.53%
Revenue growth 5YN/A
Sales Q2Q%1%
Revenue Next Year3.53%
Revenue Next 2Y-2.92%
Revenue Next 3Y-9.06%
Revenue Next 5Y-6.61%
EBIT growth 1Y103.89%
EBIT growth 3Y11.69%
EBIT growth 5Y7.28%
EBIT Next Year13.79%
EBIT Next 3Y10.08%
EBIT Next 5Y12.03%
FCF growth 1Y473.91%
FCF growth 3Y-74.97%
FCF growth 5Y-48.94%
OCF growth 1Y374.29%
OCF growth 3Y-53.28%
OCF growth 5Y-24.93%